Resources
Peer-reviewed research. from our team..
Egeiro’s scientific foundation is built on over a decade of published discovery in Alzheimer’s neuroscience.
- Relevant Publications
Selected Research Papers
2022
Extracellular vesicles enriched with amylin receptor are cytoprotective against the Aß toxicity in vitro
2021
Genetic Depletion of Amylin/Calcitonin Receptors Improves Memory and Learning in Transgenic Alzheimer’s Disease Mouse Models.
Patel A, Kimura R, Fu W, Soudy R, MacTavish D, Westaway D, Yang J, Davey R, Zajac J, Jhamandas, JH MOLECULAR NEUROBIOLOGY. 2021 July; 58
2020
Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing
Cunnane S.C., Trushina E., Morland C., Prigione A., Casadesus G., Andrews Z.B., Beal M.F., Bergersen L.H., Brinton R.D., de la Monte S., Eckert A., Harvey J., Jeggo R., Jhamandas J.H., Kann O., la Cour C.M., Martin W.F., Mithieux G., Moreira P.I., Murphy M.P., Nave K.A., Nuriel T., Oliet S.H.R., Saudou F., Mattson M.P., Swerdlow R.H., Millan M.J. Nature Reviews Drug Discovery. 2020 September; 19 (9):609-633
2019
Short amylin receptor antagonist peptides improve memory deficits in Alzheimer's disease mouse model.
Scientific Reports, July 2019; 9(1):10942
2017
Pramlintide Antagonizes Beta Amyloid (Aβ)- and Human Amylin-Induced Depression of Hippocampal Long-Term Potentiation
2017
Amylin Receptor: A Potential Therapeutic Target for Alzheimer's Disease.
2013
Role of amylin and its receptors in neurodegeneration.
2012
Neuronal receptors as targets for the action of amyloid-beta protein (Aß) in the brain